Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36242Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | MULLENS, Wilfried | - |
| dc.contributor.author | MARTENS, Pieter | - |
| dc.date.accessioned | 2021-12-16T13:31:27Z | - |
| dc.date.available | 2021-12-16T13:31:27Z | - |
| dc.date.issued | 2021 | - |
| dc.date.submitted | 2021-08-27T10:38:31Z | - |
| dc.identifier.citation | JACC-Heart Failure, 9 (8) , p. 590 -593 | - |
| dc.identifier.uri | http://hdl.handle.net/1942/36242 | - |
| dc.description.sponsorship | Drs Mullens and Martens have served on advisory boards for AstraZeneca and Boehringer Ingelheim. | - |
| dc.language.iso | en | - |
| dc.publisher | ELSEVIER SCI LTD | - |
| dc.rights | 2021 by the American College of Cardiology Foundation. Published by Elsevier. | - |
| dc.subject.other | CMR | - |
| dc.subject.other | SGLT2-inhibitors | - |
| dc.subject.other | epicardial adipose tissue | - |
| dc.subject.other | heart failure | - |
| dc.subject.other | myocardial fibrosis | - |
| dc.subject.other | Benzhydryl Compounds | - |
| dc.subject.other | Glucosides | - |
| dc.subject.other | Humans | - |
| dc.subject.other | Myocardium | - |
| dc.subject.other | Heart Failure | - |
| dc.title | Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection? | - |
| dc.type | Journal Contribution | - |
| dc.identifier.epage | 593 | - |
| dc.identifier.issue | 8 | - |
| dc.identifier.spage | 590 | - |
| dc.identifier.volume | 9 | - |
| local.bibliographicCitation.jcat | A2 | - |
| local.publisher.place | THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Editorial Material | - |
| local.class | dsPublValOverrule/author_version_not_expected | - |
| dc.identifier.doi | 10.1016/j.jchf.2021.05.006 | - |
| dc.identifier.pmid | 34325889 | - |
| dc.identifier.isi | 000678493300006 | - |
| local.provider.type | CrossRef | - |
| local.uhasselt.international | no | - |
| item.fulltext | With Fulltext | - |
| item.fullcitation | MULLENS, Wilfried & MARTENS, Pieter (2021) Empagliflozin-Induced Changes in Epicardial Fat The Centerpiece for Myocardial Protection?. In: JACC-Heart Failure, 9 (8) , p. 590 -593. | - |
| item.contributor | MULLENS, Wilfried | - |
| item.contributor | MARTENS, Pieter | - |
| item.accessRights | Open Access | - |
| crisitem.journal.issn | 2213-1779 | - |
| crisitem.journal.eissn | 2213-1787 | - |
| Appears in Collections: | Research publications | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Empagliflozin-Induced Changes in Epicardial Fat.pdf | Published version | 714.82 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
22
checked on Oct 19, 2025
WEB OF SCIENCETM
Citations
22
checked on Oct 17, 2025
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.